[DOTA0,D-Phe1,Tyr3]octreotide, Biodistribution, Indium-111, Receptor binding, Yttrium-90
dx.doi.org/10.1007/s002590050064, hdl.handle.net/1765/64878
European Journal of Nuclear Medicine
Department of Internal Medicine

de Jong, M, Bakker, W.H, Krenning, E.P, Breeman, W.A.P, van der Pluijm, M, Bernard, B.F, … Mäcke, H.R. (1997). Yttrium-90 and indium-111 labelling, receptor binding and biodistribution of [DOTA0,D-Phe1,Tyr3]octreotide, a promising somatostatin analogue for radionuclide therapy. European Journal of Nuclear Medicine, 24(4), 368–371. doi:10.1007/s002590050064